Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2017 · 10-Q
Revenue$144.04M$144.04M+10.0% vs Q3 2016 Net Income$22.17M$22.17M−26.8% vs Q3 2016 EPS Diluted$0.59$0.59−27.2% vs Q3 2016 Gross Profit$96,682,000+7.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$25,020,000−32.6% Free Cash Flowderived$21,004,000−38.8% Margins · derivedGross margin67.1%−1.6 pt vs Q3 2016
Operating margin23.3%−10.0 pt vs Q3 2016
Net margin15.4%−7.7 pt vs Q3 2016
ended Mar 31, 2017 · filed May 10, 2017 · 40 d after period end